Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

NCT: NCT06676072 · COMPLETED

NCT IDNCT06676072
StatusCOMPLETED
Start Date2024-11-22
Completion2026-04-13
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this clinical study is to demonstrate that ablation with the TactiFlex SE Ablation catheter, in conjunction with a compatible pulsed field ablation (PFA) and/or radio frequency (RF) generator, is safe and effective for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑